GANX
Gain Therapeutics Inc
1.60$
-3.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | |||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | 6,292.4 | 1,077.0 | 671.3 | 332.7 | 238.0 | 203.1 | 213.9 | 131.5 | 197.3 | 285.4 | 214.6 | 445.8 | 1,054.3 | 385.5 | 737.0 | 725.8 | 662.7 | 664.1 | 766.0 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 3.9 | 2.9 | 2.3 | 1.6 | 1.5 | 1.6 | 1.7 | 2.0 | 3.8 | 5.0 | 5.7 | 4.3 | 7.9 | 2.1 | 5.4 | 8.1 | 9.4 | 14.8 | 10.7 | 5.7 | 5.7 | 7.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 4,627.4 | 693.6 | 365.0 | 114.7 | 74.5 | 139.2 | 158.9 | 108.3 | 179.5 | 257.2 | 196.7 | 354.1 | 901.1 | 134.5 | 561.4 | 606.8 | 559.4 | 589.8 | 665.5 | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -3.1% | -6.9% | -11.0% | -22.7% | -24.8% | -32.6% | -38.4% | -40.2% | -28.9% | -29.6% | -40.9% | -35.3% | -26.7% | -76.0% | -44.2% | -31.7% | -35.1% | -33.8% | -27.5% | -17.5% | -24.1% | -22.1% | |
| Margins | |||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -971.8% | -657.6% | -631.1% | -1,112.3% | -234.4% | -386.1% | -4,613.6% | -11,030.7% | -11,069.2% | -8,718.8% | -8,417.2% | -6,374.0% | -6,066.9% | – | – | – | |
| – | – | – | -4,989.8% | -5,027.9% | -5,053.3% | -5,071.4% | -5,085.0% | – | – | – | – | -12,047.5% | -19,776.9% | -7,631.9% | -9,343.5% | -8,379.8% | -7,154.6% | -7,742.1% | -8,959.7% | -6,344.1% | -6,790.3% | -11,405.2% | -11,473.9% | -18,547.4% | -33,026.3% | -33,723.4% | -33,065.9% | -24,744.8% | -24,734.6% | -20,973.4% | -21,370.8% | – | – | – | |
| – | – | – | -5,364.6% | -5,343.1% | -5,328.8% | -5,318.6% | -5,311.0% | – | – | – | – | -12,387.7% | -19,812.4% | -7,669.0% | -9,414.7% | -8,418.8% | -7,186.4% | -7,709.8% | -8,802.4% | -6,277.6% | -6,699.8% | -11,295.1% | -11,377.1% | -18,559.4% | -32,630.2% | -33,332.6% | -32,973.7% | -24,818.5% | -25,445.7% | -22,607.7% | -23,578.9% | – | – | – | |
| – | – | – | -3,651.5% | -4,014.3% | -4,255.8% | -4,428.2% | -4,557.4% | – | – | – | – | -11,291.4% | -19,440.8% | -7,397.0% | -7,351.6% | -7,551.7% | -5,898.8% | -6,613.8% | -8,212.3% | -5,285.6% | -5,711.1% | -8,456.1% | -8,774.1% | -15,737.0% | -28,147.1% | -29,309.1% | -32,563.5% | -22,976.5% | -23,262.2% | -22,436.6% | -21,038.6% | – | – | – | |
| Returns | |||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | -33.6% | -57.7% | -12.2% | -20.4% | -32.8% | -39.9% | -46.2% | -60.1% | -71.2% | -93.2% | -128.5% | -198.8% | -303.1% | -177.0% | -244.7% | -183.3% | -239.8% | -278.1% | -362.1% | -503.1% | -328.1% | -108.6% | -151.6% | -178.1% | |
| – | – | – | – | -834.5% | -999.3% | -1,164.0% | -1,328.8% | -356.6% | – | – | -27.3% | -37.3% | -11.3% | -18.6% | -29.0% | -35.6% | -39.1% | -50.9% | -57.0% | -73.0% | -91.2% | -120.8% | -157.6% | -119.7% | -145.1% | -112.5% | -148.7% | -168.4% | -180.0% | -189.1% | -176.7% | -88.4% | -113.3% | -130.4% | |
| Balance Sheet & Debt | |||||||||||||||||||||||||||||||||||
| – | – | – | – | – | -0.1 | -0.1 | -0.1 | -0.2 | – | – | -9.2 | -6.6 | -46 | -42 | -40 | -36 | -33 | -13 | -10 | -6.5 | -5.2 | -5.5 | -3.5 | -11 | -9.9 | -16 | -11 | -9.8 | -8.5 | -6.1 | -8.3 | -20 | -16 | -13 | |
| – | – | – | – | – | -68.1% | -68.1% | -68.1% | -68.1% | – | – | 81.3% | 64.6% | 92.6% | 91.3% | 88.2% | 89.3% | 84.7% | 84.7% | 80.0% | 78.3% | 71.0% | 60.7% | 52.0% | 67.6% | 59.3% | 61.4% | 62.0% | 60.5% | 49.7% | 37.6% | 53.9% | 81.4% | 74.7% | 73.2% | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Per Share | |||||||||||||||||||||||||||||||||||
| – | – | – | -0.23 | -0.28 | -0.34 | -0.39 | -0.45 | -0.23 | -0.24 | -0.24 | -0.26 | -0.32 | -0.47 | -0.71 | -1.04 | -1.37 | -1.24 | -1.37 | -1.36 | -1.48 | -1.63 | -1.78 | -1.75 | -1.37 | -1.18 | -1.12 | -0.81 | -0.75 | -0.73 | -0.61 | -0.55 | -0.61 | -0.50 | -0.47 | |
| – | – | – | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | – | – | – | – | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | – | -0.02 | -0.02 | -0.02 | -0.04 | -0.04 | – | 0.77 | 0.55 | 3.83 | 3.48 | 3.16 | 3.43 | 2.68 | 2.27 | 1.91 | 1.59 | 1.27 | 0.90 | 0.58 | 0.78 | 0.48 | 0.61 | 0.34 | 0.27 | 0.20 | 0.12 | 0.17 | 0.56 | 0.33 | 0.26 | |
| – | – | – | -0.15 | -0.21 | -0.27 | -0.33 | -0.39 | -0.17 | -0.20 | -0.20 | -0.23 | -0.29 | -0.46 | -0.69 | -0.81 | -1.23 | -1.02 | -1.17 | -1.27 | -1.25 | -1.39 | -1.33 | -1.35 | -1.17 | -1.01 | -0.99 | -0.80 | -0.70 | -0.67 | -0.61 | -0.49 | -0.56 | -0.46 | -0.44 | |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.